Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1,001 - 1,050 out of 15,243

Document Document Title
WO/2014/075563A1
Disclosed is a preparation method of antimicrobial traditional Chinese medicine compound total flavonoid. The traditional Chinese medicine compound total flavonoid prepared by using the method has an antimicrobial effect. Also disclosed ...  
WO/2014/074365A1
The present invention provides compounds of Formula I. Wherein Rl, L, and A are as described herein, or a pharmaceutical salt thereof, processes for preparing the compounds, and methods of treating a condition, such as hypertriglyceridem...  
WO/2014/071438A1
This invention relates to polyphenolic compounds, in particular ethoxylated polyphenolic compounds and the use of such compounds in disease prevention, disease treatment, and life extension in humans and animals. The invention also relat...  
WO/2014/072017A1
The application relates to a compound of a formula (I) which is suitable for use as a functional material in electronic devices.  
WO/2014/071480A1
The present invention describes a method for fractionating an R. mangle extract, by means of which it is possible to efficiently concentrate a significant quantity of complex tannins. The fraction obtained by means of the proposed method...  
WO/2014/074845A1
A photoactive coumarin monomer includes a substituted coumarin molecule that has at least two functional groups may be used to produce a polymer with a coumarin unit or a coumarin derivative unit as part of the polymer backbone. The poly...  
WO/2014/071369A1
The invention provides tricyclic compounds and their use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making various tricyclic compounds are provided. The compounds are contemplated to have a...  
WO/2014/070108A1
A fluorescent rosamine dye having specificity for neural stem cells, specifically, proliferative neural stem cells, and represented by Structural Formula (I): wherein X is an anion, is described herein. Synthesis of the fluorescent rosam...  
WO/2014/071363A1
The invention provides tricyclic compounds and their use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making various tricyclic compounds are provided. The compounds are contemplated to have a...  
WO/2014/071134A1
In certain embodiments, the disclosure relates to 7,8-dihydoxyflavone and 7,8-substituted flavone derivatives, such as those described by formula provided herein, pharmaceutical compositions, and methods related thereto. In certain embod...  
WO/2014/063504A1
Provided in the present invention is a method for extracting dihydroquercetin from the root of larch trees in a specific regions, by utilizing the resource advantage that the root (200 mm below the earth surface) of tree species has a re...  
WO/2014/064716A1
An embodiment of the present invention pertains to molecules of general formula A and formula B, namely substituted hexahydro-(5H)-1-benzopyran-5-one (or hexahydro-(5H)-chromen-5-one) derivatives and substituted tetrahydro-(5H)-1- benzop...  
WO/2014/061752A1
A compound characterized in being represented by any of general formulae (1) to (5); a tautomer or a geometric isomer thereof; a salt of the compound, tautomer, or geometric isomer; and the like. (In the formulae, X1 represents a single ...  
WO/2014/062965A1
The present invention relates to novel 2-cycloalkyl resorcinol compounds; to pharmaceutical compositions comprising the compounds; and to methods of preparing the compounds and uses thereof. The disclosed compounds can bind to and modula...  
WO/2014/061764A1
A compound having an exceptional blood-sugar-reducing effect and represented by general formula (I), and a pharmaceutically acceptable salt thereof. In the formula, X is =C(R8)-, -CH(R8)-, =N-, or -O-; Y is =C(R9)-, -CH(R9)-, or =N-; Z i...  
WO/2014/033620A3
The present invention provides the compounds of formulae (3) and (1 ) wherein n is 0 or 1, R13 and R14 are the same or different and are selected from the group consisting of NHR310, NR311R312, OR313, SR314 and R315, or R13 and R14 toget...  
WO/2014/056038A1
The present disclosure provides a compound of the following formula, racemates, enantiomers, prodrugs and salts thereof: Formula (I). Also provided is the use of these compounds for the treatment of ischemia and reperfusion injuries. Fur...  
WO/2014/057727A1
The purpose is to provide a method for manufacture a fraction containing nobiletin and tangeretin in high concentration and having excellent safety, economic efficiency, and commercialization. The above-stated purpose is achieved by a me...  
WO/2014/058274A1
The present invention relates to a production method for induced-pluripotent-stem-cell-derived differentiated cells, from which undifferentiated induced pluripotent stem cells (iPS) have been eliminated, the method comprising the steps o...  
WO/2014/059228A1
Aqueous compositions comprising at least one hydrotrope and at least one active compound. The at least one hydrotrope is present in an amount: (a) effective to solubilize said at least one active compound in water; and/or (b) effective t...  
WO/2014/057103A1
Inhibitors of viral replication of formula (I), their process of preparation and their therapeutical uses. The present invention relates to compounds, their use in the treatment or the prevention of viral disorders, including HIV.  
WO/2014/054174A1
A method for producing a low-polymerization-degree proanthocyanidin, comprising heating an aqueous solution of a proanthocyanidin raw material at a low temperature in the presence of a compound containing a sulfo group to produce a natur...  
WO/2014/008192A3
The present invention is directed to a method and device to isolate compounds from plant material using vibrational pulsing, vibrational decanting, vibrational sieving and vibrational rinsing. In an embodiment of the invention, a suscept...  
WO/2014/054785A2
The present invention provides an in-plane switching-type liquid crystal display element imparted with a high-efficiency alignment control function, and having excellent burn-in properties. The present invention also provides a manufactu...  
WO/2014/053460A1
The present invention relates to compositions and methods for modulating the degree of adipose tissue deposited intramuscularly in cattle by administration of a retinoic receptor antagonist or inverse agonist and compounds for use in suc...  
WO/2014/048313A1
Disclosed are a compound as represented by formula (I), which is a condensation product of a theanine derivative and a carboxylic acid coumarin derivative, a compound as represented by formula (II), which is an intermediate of the conden...  
WO/2012/154676A9
The invention provides tricyclic compounds and their use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making various tricyclic compounds are provided. The compounds are contemplated to have a...  
WO/2014/046224A1
The purpose of the invention is to provide a novel coumarin derivative or pharmaceutically acceptable salt thereof and a drug containing this compound as an active ingredient. This coumarin derivative or pharmaceutically acceptable salt ...  
WO/2014/041125A1
The present invention relates to novel inhibitors of p21. These inhibitors are useful as therapeutic agents for promoting cell regeneration and in the treatment of cancer. Improvement of cell regeneration is particularly desirable in pat...  
WO/2014/038221A1
The present invention provides: a method that is for preparing a crystal structure analysis sample resulting from an organic compound molecule that determines molecular structure being regularly arranged within hollows and minute pores w...  
WO/2014/038220A1
The present invention is: a guest-compound-enveloping polymer-metal-complex crystal characterized by at least one selected from an aliphatic hydrocarbon, an alicyclic hydrocarbon, an ether, an ester, an aromatic hydrocarbon, a halogenate...  
WO/2014/032183A1
A compound of formula (I) as well as pharmaceutical compositions comprising same is provided. An extract of a plant belonging to a species of Populus, the extract comprising this compound is also provided. These can be used as antibacter...  
WO/2014/031784A1
Disclosed herein are new antiviral compounds, together with pharmaceutical compositions that include one or more antiviral compounds, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating...  
WO/2014/030006A1
Cellulosic fibrous materials are described which are impregnated with a bioflavonoid composition, the bioflavonoid content of the composition comprising at least naringin and neohesperidin. The use of such impregnated materials is also d...  
WO/2014/031762A1
Provided are benzocyclooctyne compounds of formula (I). These compounds undergo strain-promoted azide-alkyne cyclo additions (SPAAC) without presence of toxic metal catalysts. The provided compounds are useful for diagnosis and imaging o...  
WO/2014/031755A1
Disclosed herein are novel derivatives of fendiline, including compounds of the formula: wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising these derivativ...  
WO/2014/030688A1
The purpose of the present invention is to provide a compound having bone formation promoting activity. The solution is a compound having general formula (I) or a pharmaceutically acceptable salt thereof. [In the formula, R1 is a methyl ...  
WO/2014/030053A1
Disclosed in certain embodiments is a system and method of providing a dronabinol oral solid dosage form with increased stability.  
WO/2014/030005A1
Polymeric materials are described which have a bioflavonoid coating, the bioflavonoid content of the coating comprising at least naringin and neohesperidin. The use of such coated polymeric materials is also described as well as the proc...  
WO/2011/042423A3
Disclosed is the use of benzotropolone derivatives of formula (1), wherein R1, R2 and R7 independently from each other are hydrogen; C1-C3alkyl; or COR8; R3 is hydrogen; or COOR9 R4 is hydrogen; or C1-C3alkyl; R5 is hydrogen; hydroxy; C1...  
WO/2014/028025A1
Disclosed is a compound for treatment of Myotonic Dystrophy type 1 having the formula (I) wherein X is selected from the group consisting of O, N, C, or S, Y is a homo- or heteroatomic 5-membered ring comprising one or more atoms selecte...  
WO/2014/025651A1
Chroman compounds and derivatives of Formula (I) are useful inhibitors of TRPM8. Such compounds are useful in treating a number of TRPM8 mediated disorders and conditions and may be used to prepare medicaments and pharmaceutical composit...  
WO/2014/025370A1
A method of quenching excited state energy from a photodegradable pigment that has been excited by absorption of light having a wavelength in the wavelength range of 290 - 800 nm, comprising reacting a pigment with a conjugated fused tri...  
WO/2014/023846A1
The present invention relates to a method of preparing a tocopherol or protected tocopherol with a reduced content of phenolic compound or protected phenolic compound, particularly of (2R,3R)-2,3,4,6,7-pentamethyl-2- (4,8,12-trimethyltri...  
WO/2013/192517A3
The present invention provides compounds of Formula I, pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting fungal or parasitic growth. The compo...  
WO/2014/023845A1
The present invention relates to a method of preparing a tocopherol or protected tocopherol with a reduced content of dehydrotocopherol or protected dehydrotocopherol comprising the step of contacting tocopherol or protected tocopherol i...  
WO/2014/023849A1
The present invention relates to a method of preparing a tocopherol with an increased color stability comprising the step of contacting tocopherol in neat or in the form of a highly concentrated solution with an acid activated bleaching ...  
WO/2014/023848A1
The present invention relates to a method of preparing a protected tocopherol with a reduced content of free tocopherol, comprising the step of contacting the tocopherol used for the preparation of the protected tocopherol in neat or in ...  
WO/2014/020038A1
Disclosed is a method for the synthesis of spiro[2.5]octane-5,7-dione useful as intermediate in the manufacture of pharmaceutically active ingredients. Also disclosed are novel intermediates used in the synthesis of this compound.  
WO/2014/016314A1
A compound having the formula (I), for use in treating a disease; a composition comprising said fused quinonic compound of formula (I) and at least one pharmaceutically acceptable carrier; as well as a method of modulating a Janus Kinase...  

Matches 1,001 - 1,050 out of 15,243